Drug-Coated Stents Will Pay Their Way If Priced At $2,500 Or Below – Cohen

The ability of drug-eluting stents to reduce the need for revascularization procedures justifies a price premium of up to $1,500 over regular stents, according to a cost-efficiency model by cardiologist David Cohen, MD, Beth Israel Deaconess Medical Center

More from Archive

More from Medtech Insight